Radiotherapy Journey on OncoDaily in 2025 follows a field that keeps moving fast. New tools, better planning, and more personalized decision-making are changing how radiotherapy is delivered and how patients experience treatment. OncoDaily is tracking these updates throughout the year—from technique and workflow improvements to the day-to-day questions around combining radiotherapy with immunotherapy and targeted therapies—keeping the focus on what matters in practice for both patients and clinicians.
Throughout this year, OncoDaily has published a series of 76 articles dedicated to radiotherapy. These pieces reflect the ongoing changes in the field, offering valuable insights for both healthcare professionals and patients.
Patient-Educational Articles on OncoDaily
In 2025, patient education remained a central part of OncoDaily’s radiotherapy coverage. We published a series of articles aimed at helping patients and caregivers better understand radiotherapy, from the basics of how treatment works to what to expect before, during, and after therapy. These articles were written in plain language, avoiding technical terms where possible, and focused on practical questions patients often ask—such as treatment planning, side effects, safety, and daily life during radiotherapy. By making reliable information easier to access, OncoDaily aims to support informed decision-making and reduce uncertainty for patients navigating their radiotherapy journey.
Radiotherapy For Soft Tissue Sarcomas
Professional Updates on OnocDaily
In 2025, OncoDaily’s radiotherapy coverage was designed to serve both patients and professionals. Alongside patient-education articles written in clear, accessible language, we published content tailored for radiation oncologists, residents, and oncology professionals. This included concise summaries of newly published scientific papers, highlights of practice-relevant findings, and timely alerts on important new research. By combining patient-focused education with professional summaries and literature updates, OncoDaily aims to support informed care, ongoing learning, and day-to-day clinical decision-making in radiation oncology.
Protons Vs Photons: What We Know At The End of 2025?Â
Beyond clinical practice
We have also covered practical and professional topics that shape everyday work in radiation oncology—things that often matter just as much as new data. This includes discussions around radiation oncology salaries and compensation trends, how pay can differ by country or practice setting, and what factors typically influence income over time. We’ve explored training pathways and residency programs, including what applicants can expect during residency, how programs are structured, and which skills and experiences tend to matter most early on. We’ve also written about career development, from choosing a subspecialty and building a clinical-academic profile to navigating the first years after residency, mentorship, and long-term growth in the field.
This broader approach is meant to support the full radiation oncology community—not only patients and caregivers, but also residents, early-career specialists, and practicing professionals who are dealing with real-world decisions about training, workload, workplace culture, and career direction.
Our Article About Salaries In Radiation Oncology
Choosing the Radiation Oncology School in US
OncoDaily at ESTRO 2025 in Vienna
At ESTRO 2025 in Vienna, OncoDaily delivered expanded, day-by-day coverage through an official collaboration with ESTRO, combining onsite reporting with strong editorial support from our office. Our goal was to capture the meeting as it unfolded—highlighting major clinical updates, emerging research directions, and practical takeaways relevant to radiation oncology teams worldwide.
During the congress, we produced 16 original YouTube videos, featuring expert interviews, short recaps, and direct reactions to key sessions. Several of these videos performed strongly, helping bring conference discussions to a wider audience beyond the venue. In parallel, our editorial team published 28 original articles, written both onsite in Vienna and from Yerevan. These articles focused on the content that matters most in practice: important presentations, expert perspectives, session highlights, and broader themes shaping the field.
Beyond our original reporting, we also worked to strengthen the broader ESTRO community’s visibility by sharing and amplifying content created by other participants—including posts, interviews, and updates—across OncoDaily’s website and social media channels. This helped connect voices from across the congress and extend the life of key discussions after sessions ended.
To maximize reach, all ESTRO 2025 coverage was distributed across Facebook, LinkedIn, X, BlueSky, and Telegram, ensuring the content reached clinicians, researchers, residents, and the wider oncology audience in different regions and formats. Overall, our ESTRO 2025 coverage aimed to be timely, practical, and easy to follow—bringing the key messages from Vienna to the global radiation oncology community.
Our Interview with ESTRO President
Our Article About EMBRACE II Trial
Our Article About PORTEC-4a Trial
OncoDaily at ESMO 2025 in Berlin
At ESMO 2025, OncoDaily covered the meeting in real time, following the biggest data releases, headline sessions, and expert takeaways as they happened. We focused on the updates most likely to influence clinical practice—new trial results, guideline-shaping discussions, and major trends across disease sites—while keeping the reporting clear and easy to scan during a busy congress week.
Our team turned key moments into fast, structured coverage, combining news recaps, paper alerts, and interviews with clinicians and researchers. Instead of trying to cover everything, we prioritized what was most relevant: what changed, why it matters, who it applies to, and what questions remain. By packaging updates in a direct, media-style format, OncoDaily helped clinicians, residents, and the wider oncology community stay connected to ESMO 2025—even if they couldn’t attend every session. The goal was simple: make the most important congress information easier to follow, faster to understand, and useful in real-world oncology practice.
CompARE Phase III Trial — Standard CRT Remains Benchmark as Durvalumab Sequencing Shows no OS Gain
Marking World Radiotherapy Awareness Day
In 2025, OncoDaily also marked World Radiotherapy Awareness Day on September 7 by focusing our coverage on the role of radiotherapy in cancer care. On that day, we shared articles and educational content aimed at improving understanding of how radiotherapy is used across different cancer types, what patients can expect during treatment, and why access to accurate information matters. The coverage was intended to raise awareness among patients, caregivers, and healthcare professionals, while also reinforcing the importance of radiotherapy as a core component of modern oncology.
World Radiotherapy Awareness Day, September 7: Recognizing the Hidden Hero of Cancer Care
In OncoDaily TV episode, Prof. Sandra Turner (University of Sydney), a radiation oncologist specializing in genitourinary cancers and sarcoma, discusses how the global oncology community can work toward more equitable access to modern radiotherapy. The conversation focuses on the challenges patients face in different regions, including disparities in infrastructure, workforce availability, training, and access to advanced technology. Prof. Turner also reflects on practical steps that could help reduce these gaps, emphasizing collaboration, education, and sustainable solutions to improve access to radiotherapy worldwide.
Final Thoughts
Throughout 2025, OncoDaily’s radiotherapy coverage reflected the full scope of the field—from patient education and scientific updates to professional realities, global meetings, and broader questions around access and equity. By combining clear explanations for patients, practical summaries for professionals, and timely reporting from major oncology congresses, we aimed to make radiotherapy more visible, understandable, and useful in everyday practice.
We’re grateful to everyone who read, watched, shared, commented, and collaborated with us throughout the year—clinicians, researchers, residents, advocates, patients, and caregivers. Your support and engagement shaped this journey. We look forward to continuing this work in 2026, with more coverage, more conversations, and more opportunities to highlight what matters in radiation oncology.
Written By Aren Karapetyan, MD